Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06485089 · ClinicalTrials.gov registry record
Effects of Tirzepatide on Blood, Imaging and Breast Tissue Biomarkers
A clinical trial of Obesity and Breast Cancer Risk, sponsored by University of Kansas Medical Center.
- Active
- Registry status
- 20
- Enrollment target
- 2
- Study locations
NCT06485089 is a study of Obesity and Breast Cancer Risk that is active but no longer recruiting, run by University of Kansas Medical Center. The registered enrollment target is 20 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (98% lower). The trial reports 2 study locations across 1 state.
The verdict
NCT06485089, a study of Obesity and Breast Cancer Risk, is active but no longer recruiting, sponsored by University of Kansas Medical Center.
- ACTIVE NOT RECRUITING
- Registry status
- 20 participants
- Enrollment target
- 2
- Study locations
Study Summary
Evaluation of biomarkers for risk of developing breast cancer in women with obesity who are using tirzepatide to achieve weight loss.
Conditions Studied
Interventions
- DRUG tirzepatide
Study Locations (2)
Kansas
- University of Kansas Medical Center - Kansas City
- University of Kansas Medical Center Breast Cancer Prevention Center - Westwood
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2024-09-14 |
| Est. Completion | 2026-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06485089
The ClinicalTrials.gov registry entry for NCT06485089 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (98% lower). The listed sponsor is University of Kansas Medical Center, which has 408 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Obesity appearing as the primary indexed condition, and to 1 intervention - of which tirzepatide is the first listed.
NCT06485089 reports 2 study locations spanning 1 distinct geographic area - top geographies include Kansas.
Frequently Asked Questions
What is clinical trial NCT06485089 about?
NCT06485089 is a clinical study titled "Effects of Tirzepatide on Blood, Imaging and Breast Tissue Biomarkers". Evaluation of biomarkers for risk of developing breast cancer in women with obesity who are using tirzepatide to achieve weight loss.
What is the current status of trial NCT06485089?
This trial is currently active not recruiting. The enrollment target is 20 participants. The study started on 2024-09-14. Estimated completion is 2026-04.
What conditions does trial NCT06485089 study?
This clinical trial studies the following conditions: Obesity, Breast Cancer Risk.
What interventions are being tested in trial NCT06485089?
The interventions under investigation include: tirzepatide (DRUG).
Who is sponsoring clinical trial NCT06485089?
This trial is sponsored by University of Kansas Medical Center, which has 408 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06485089 being conducted?
This trial has 2 study locations across Kansas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Obesity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Hip Flexion Feedback System for Exercise Monitoring in Individuals With Osteoarthritis and Obesity
RECRUITING · Phase 1
-
Metabolic Adaptations to Weight Loss With and Without Exercise
RECRUITING · NA
-
Testing an Integrated PTSD and Weight Management Intervention: A Hybrid Type 1 Trial
RECRUITING · NA
-
TIRzepatide for the Treatment of Obesity in Patients With Atrial Fibrillation
RECRUITING · Phase 2
-
Tirzepatide: Reversal of Lipotoxicity and Adipose Tissue Dysfunction in Humans With Overweight/Obesity
RECRUITING · Phase 2
-
Tai Chi as a Novel Strategy to Increase Physical Activity Among Adults Pursuing Metabolic and Bariatric Surgery
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.